BioWorld

Sep. 9, 2003

View Archived Issues

Axon Branches Of Young Mice Push Fast, Retract Within Minutes While Aging Synapses Get Stabler

Read More

Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug

Read More

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Read More

Other News To Note

Read More

Regeneron, Aventis In Potential $485M Alliance On VEGF Trap

Regeneron Inc.'s fortunes - and its stock - experienced an upswing Monday with the disclosure of a potential $485 million deal focused on its VEGF Trap product candidate with Aventis SA. (BioWorld Today) Read More

Biovitrum Lands Blockbuster Deal With Amgen In Metabolics

Read More